Meet Deepak Kanojia, Ph.D., our Principal Scientist, In Vivo Pharmacology. In this pivotal role, Dr. Kanojia leads the design and execution of the in vivo studies that are integral to translating our early-stage discoveries into viable treatment options. His work is crucial in our mission to bringing impactful and innovative #ADCs to more #patients. Learn what inspires Dr. Kanojia, below:?? ? #MeetMythic?
Mythic Therapeutics, Inc.的动态
最相关的动态
-
Gain insight into Patient-Centric sampling when you attend part 2 of the New Horizons in Clinical Pharmacology webinar series: May 21 at 12 pm ET: https://bit.ly/3QnmDi4
-
-
Is your research investigating the representation of/or primary inclusion of participants from underrepresented groups in clinical pharmacology research? Submit it for publication in the upcoming #CTSjournal special collection focusing on DEI! https://bit.ly/3VCRgmy
-
-
Precision Medicine is one exemplary manifestation of patient-centric care - learn more about the #ASCPT2025 theme of Patient-Centric Clinical Pharmacology in this piece from #CPTjournal: https://bit.ly/3JrWPgw
-
-
Present at The Extracellular Matrix Pharmacology Congress in Copenhagen now? Don't miss Dr. Noah Fereidoni's highlighted poster presentation P107 from 17:00 today! Learn more about full-length laminins and how they are crucial for recreating the cellular niche in vitro. #laminin #ECM2024 #matrixbiology #BioLamina
-
-
Check out this amazing study investigating the mechanism of quercetin in the management of diabetic foot ulcer by network pharmacology and molecular docking: https://lnkd.in/d8MWYgqP #quercetin #diabeticfootulcer #ModernChineseMedicine #Research?
-
-
ORIC-UOS congratulates Dr. Ambreen Malik Uttra, Lecturer, College of Pharmacy, University of Sargodha on the publication of two research papers titled: Appraisal of anti-inflammatory and immunomodulatory potential of ramipril against Freund's adjuvant-provoked arthritic rat model & Assessment of the anti-arthritic and immunosuppressive potential of enalapril by using network pharmacology, molecular docking and experimental pharmacology approaches published in Inflammopharmacology & Farmacia" Category W (Impact factors 5.8 & 1.6) #UOSORIC?#UOSCollegeofpharmacy?#UOSResearchers?#UOSFaculty?#UOSleadingtoresearch?#Commercialization?#uosinnovation
-
-
[NEW] Preclinical Human Vascular Pharmacology ?? Do you need to test your compounds on HUMAN VESSELS? PhysioStim provides predictive and adaptative models to evaluate potential #hemodynamic effects. ?? Let's start a conversation! ([email protected]) #humanvascular #bloodpressure #secondarypharmacology #translationalmodel #humanassay #hemodynamiceffect #drugdevelopment
-
-
WorkingDocs, your reliable source for academic and professional success! We specialize in offering top-tier, custom-written essays, research papers, and study materials designed to meet your specific requirements.
Test Bank for Roach's Introductory Clinical Pharmacology 12th Edition by Susan M Ford - Complete, Elaborated and Latest Test Bank. ALL Chapters
-
Are you interested in what our research groups are working on at the Department? Taufiq Rahman, a co-author of the paper below, investigates how various cellular signals coordinate the activation of two-pore channels and TRP mucolipins.
Yuan, Patel (UCL), Ja?lan, Bracher, Grimm (Ludwig-Maximilians-Universit?t München) and Rahman (Department of Pharmacology, University of Cambridge) discuss coordinating activation of endo-lysosomal two-pore channels and TRP mucolipins for our "GRC Channeling Calcium Signals to Therapeutics" #SymposiumSet! ??https://buff.ly/49OSz5u
-
